Aaru vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Aaru

EmergingArtificial Intelligence

AI Synthetic Consumer Research

Series A at $1B headline valuation (Dec 2025) led by Redpoint Ventures. Customers include Accenture, EY, Interpublic Group. AI synthetic populations for instant market research and polling.

About

Aaru creates AI "synthetic populations" — computational models of human demographic groups that simulate survey responses, focus group reactions, and behavioral predictions based on real-world data — enabling instant market research and polling without recruiting and surveying actual participants. The company raised a Series A at a $1 billion headline valuation in December 2025, led by Redpoint Ventures. Customers include Accenture, EY, and Interpublic Group, three of the world's largest professional services and marketing firms.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.